| Asthma trial Part A enrolment and program update | RNS | 04.06.21 | 07:00:03 |
| Total Voting Rights | RNS | 01.06.21 | 08:52:45 |
| Result of AGM | RNS | 24.05.21 | 10:48:51 |
| Update on Data for Phase II Study of Blautix | RNS | 24.05.21 | 07:00:07 |
| Presentation of Blautix IBS Phase II at DDW 2021 | Reach | 17.05.21 | 07:00:15 |
| Collaboration with Parkinson’s UK | Reach | 19.04.21 | 07:00:09 |
| Directors’ Subscription for new Ordinary Shares | RNS | 16.04.21 | 07:00:06 |
| Annual Financial Report | RNS | 15.04.21 | 17:00:05 |
| Participation in Jefferies Therapeutics Summit | Reach | 15.04.21 | 07:00:04 |
| Holding(s) in Company | RNS | 12.04.21 | 14:26:04 |
| How to Convert AIM Ordinary Shares into Nasdaq ADS | Reach | 07.04.21 | 07:00:13 |
| Final Results | RNS | 01.04.21 | 07:00:09 |
| Holding(s) in Company | RNS | 26.03.21 | 15:21:18 |
| Holding(s) in Company | RNS | 25.03.21 | 12:08:59 |
| Holding(s) in Company | RNS | 25.03.21 | 08:00:02 |
| Completion of Merger | RNS | 22.03.21 | 07:00:08 |
| Result of Meeting | RNS | 18.03.21 | 13:25:04 |
| 4D Pharma Announces Private Placement | RNS | 17.03.21 | 13:00:01 |
| Investor conference participation | RNS | 03.03.21 | 07:00:07 |
| Exercise of Options and Total Voting Rights | RNS | 01.03.21 | 17:49:27 |
